ArticleFrontiers in immunology2023

Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.

Patricia Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.